PANXEON reads three signals to catch pancreatic cancer sooner
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Editor's Top Picks
One AI watchdog now covers every ward in Abu Dhabi
A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…
Your one-stop resource for medical news and education.
Pathos AI bets $125M on ADC its agent platform flagged
Pathos AI is paying $125M upfront for an Alphamab Oncology ADC that its Foundry agent platform flagged, plus a new…
Gates and Bezos back LifeMine’s $188M fungal drug revival
LifeMine is reviving its fungal genome platform with $188M from Bill Gates, Jeff Bezos and RA Capital, and will soon…
First AI-found brain target advances in Recursion-Roche pact
The first neuroscience target found through Recursion's $12B AI pact with Roche and Genentech is moving into an early discovery…
AI pilots prove value then stall in most health systems
A Carta Healthcare survey finds 71% of organizations with measurable AI wins are not scaling them, with EHR integration the…
Cancer trial matchmaker Massive Bio climbs OpenAI partner ranks
The oncology trial matching company joins OpenAI's Select tier to pair frontier models with cancer care workflows.
Remote care platform HealthSnap banks $25M to widen AI reach
The Miami chronic care platform lands a $25M growth facility to scale its AI-powered remote monitoring.
Atropos real-world evidence plugs into Health Universe AI agents
Clinicians using the AI workflow platform can now pull patient-specific answers from Atropos' real-world data.
Anthropic’s Claude takes on trial enrollment delays in ICON pact
CRO giant ICON will weave Anthropic's Claude into site selection, feasibility and enrollment monitoring across its agentic Orbis platform.